biomedicina slovenica

"DIABETES MELLITUS, NON-INSULIN-DEPENDENT" : 332

  1. Kovačec Simona; Krajnc Mitja; Čokolič Miro; Zavratnik Andrej
    Sladkorna bolezen in nosečnost
    [Diabetes in pregnancy]
    2012 ►
  2. Makuc Jana; Petrovič Danijel
    Diabetic nephropathy in type 2 diabetes: MPO T-764C genotype is associated with oxidative stress
    2012 ►
  3. Kariž Stojan; Nikolajević-Starčević Jovana; Petrovič Danijel
    Association of manganese superoxide dismutase and glutathione S-transferases genotypes with myocardial infarction in patients with type 2 diabetes mellitus
    2012 ►
  4. Schnell Oliver; Alawi Hasan; Battelino Tadej; Ceriello Antonio; Diem Peter; Felton Anne-Marie; Grzeszczak Wladyslaw; Harno Kari; Kempler Peter; Saltman Ilhan; Verges Bruno
    The role of self-monitoring of blood glucose in glucagon-like peptide-1-based treatment approaches: a European expert recommendation
    2012 ►
  5. Makuc Jana; Petrovič Danijel
    No association between NOS2 and NOS3 polymorphisms and diabetic nephropathy in type 2 diabetics
    2012 ►
  6. Perše Martina
    Physical activity, dietary fat and colorectal cancer
    2012 ►
  7. Battelino Tadej; Bode Bruce W
    Continuous glucose monitoring in 2011
    2012 ►
  8. Schnell Oliver; Alawi Hasan; Battelino Tadej; Ceriello Antonio; Diem Peter; Felton Anne; Grzeszczak Wladyslaw; Harno Kari; Kempler Peter; Satman Ilhan; Verges Bruni
    Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: a European perspective and expert recommendation
    2011 ►
  9. Primožič Simona; Tavčar Rok; Avbelj Magdalena; Dernovšek Mojca Zvezdana; Ravnik-Oblak Maja
    Specific cognitive abilities are associated with diabetes self-management behavior among patients with type 2 diabetes
    2012 ►
  10. Cilenšek Ines; Mankoč Sara; Globočnik-Petrovič Mojca; Petrovič Daniel
    GSTT1 null genotype is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes, whereas GSTM1 null genotype might confer protection against retinopathy
    2012 ►
  11. Šantl-Letonja M; Letonja M; Nikolajević-Starčević JN; Petrovič D
    Association of manganese superoxide dismutase and glutathione S-transferases genotypes with carotid atherosclerosis in patients with diabetes mellitus type 2
    2012 ►
  12. Nikolajević-Starčević Jovana; Globočnik-Petrovič Mojca; Petrovič Danijel
    A1/A2 polymorphism of the glycoprotein IIIa gene and diabetic retinopathy in Caucasians with type 2 diabetes
    2011 ►
  13. Buse JB; Rosenstock J; Sesti G; Janež A
    Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
    2009 ►
  14. Pratley RE; Nauck M; Montanya E; Janež A
    Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
    2010 ►
  15. Doehner Wolfram; Haeusler Karl Georg; Endres Matthias; Anker Stefan D; MacNee William; Lainščak Mitja
    Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease
    2011 ►
  16. Cilenšek Ines; Hercegovac Amela; Nikolajević-Starčević Jovana; Vukojević Katarina; Saraga-Babić Mirna; Milutinović-Živin Aleksandra
    Polymorphisms of interleukin-4, -10 and 12B genes and diabetic retinopathy
    2011 ►
  17. Letonja Mitja; Nikolajević-Starčević Jovana; Šantl-Letonja Marija; Petrovič Danijel
    Association of the -262C/T polymorphism in the catalase gene promoter with carotid atherosclerosis in Slovenian patients with type 2 diabetes
    2011 ►
  18. Kariž S; Petrovič D
    Interleukin-18 promoter gene polymorphisms are not associated with myocardial infarction in type 2 diabetes in Slovenia
    2011 ►
  19. Pleskovič Aleš; Vraspir-Porenta Olga; Zorc-Pleskovič Ruda; Petrovič Danijel; Zorc Metka; Milutinović Aleksandra
    Deficiency of mast cells in coronary artery endarterectomy of male patients with type 2 diabetes
    2011 ►
  20. Kariž Stojan; Zorc Marjeta; Petrovič Danijel
    Srčno-žilni dejavniki tveganja in visoko občutljivi C-reaktivni protein pri bolnikih s sladkorno boleznijo in nedavno prebolelim srčnim infarktom
    [Cardiovascular risk factors and high sensitivity C-reactive protein in diabetic patients with recent myocardial infarction]
    2011 ►
  21. Battelino Tadej; Bode Bruce W
    Continuous glucose monitoring in 2010
    2011 ►
  22. Cilenšek Ines; Hercegovac Amela; Terzić Rifet; Globočnik-Petrovič Mojca; Petrovič Daniel
    Polymorphisms of interleukin-8 and -18 genes and diabetic retinopathy
    2010 ►
  23. Pongrac-Barlovič Draženka; Cooper Mark E
    Arterial hypertension defeated? Attacked from another angle
    2009 ►
  24. Zaletel J; Pongrac-Barlovič D; Preželj J
    Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with type 2 diabetes
    2010 ►
  25. Battelino N; Bratina N
    Dekompenzirana sladkorna bolezen tipa 2 pri mladostniku
    [Decompensated type 2 diabetes mellitus in an adolescent]
    2009 ►
  26. Rocic B; Bedernjak-Bajuk N; Rocic P; Weber DS; Boras J; Lovrencic MV
    Comparison of antihyperglycemic effects of creatine and metformin in type II diabetic patients
    2009 ►
  27. Reschner Hrvoje; Milutinovič Aleksandra; Petrovič Danijel
    The PECAM-1 gene polymorphism - a genetic marker of myocardial infarction
    2009 ►
  28. Kariž S; Grabar D; Krkovič M; Osredkar J; Petrovič D
    Polymorphisms in the promoter region of the basic fibroblast growth factor gene are not associated with myocardial infarction in a Slovene population with type 2 diabetes
    2009 ►
  29. Fon-Tacer Klementina
    Hormon stradanja fibroblastni rastni dejavnik 21 - novo zdravilo za debelost in metabolni sindrom?
    [Fasting hormone fibroblast growth factor 21 - new therapy for obesity and metabolic syndrome?]
    2009 ►
  30. Bavec Aljoša; Ličar Alenka
    Functional characterization of N-terminally GFP-tagged GLP-1 receptor
    2009 ►
  31. Bavec A
    Constructing glucagon like peptide-1 receptor fused with derivatives of GFP for visualizing protein-protein interaction in living cells
    2009 ►
  32. Reschner H; Steblovnik K; Milutinovič A; Petrovič D
    The TNFalpha gene G(-308)A polymorphism as a marker for myocardial infarction in type 2 diabetes mellitus
    2008 ►
  33. Globočnik-Petrovič Mojca; Osredkar Joško; Saraga-Babić Mirna; Petrović Daniel
    K469E polymorphism of the intracellular adhesion molecule I gene is associated with proliferative diabetic retinopathy in caucasians with type 2 diabetes
    2008 ►
  34. Mrevlje Franc; Piletič Miliovoj; Senčar-Božič Petra
    Insulin Detemir izboljša glikemično urejenost in ima nevtralen učinek na telesno maso v slovenski kohorti raziskave Predictive - klinične izkušnje v Sloveniji
    [Insulin Detemir improves glycemic control and is weight neutral in the Slovenian cohort of the Predictive study - clinical experience in Slovenija]
    2008 ►
  35. Atanasijević-Kunc Maja; Drinovec Jože; Ručigaj Simona; Mrhar Aleš
    Modelling of the risk factors and chronic diseases that influence the development of serious health complications
    [Modeliranje dejavnikov tveganja in kroničnih bolezni, ki vplivajo na razvoj hujših zdravstvenih zapletov]
    2008 ►
  36. Cilenšek Ines; Krkovič Miha; Osredkar Joško; Petrovič Daniel
    Polymorphisms (1663 T/C, 251 A/T) in the interleukin-8 gene are not associated with myocardial infarction in Caucasians with type 2 diabetes
    [Polimorfizmi (1663 T/C, 251 A/T) gena za interlevkin-8 niso povezani s srčnim infarktom pri belcih s sladkorno boleznijo tipa 2]
    2008 ►
  37. Davies M; Lavalle-Gonzalez F; Storms F; Gomis R; Battelino T; Koselj M; Ravnik-Oblak M; Šubic J; Tomažič M; Urbančič V; Vrtovec M
    Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial
    2008 ►
  38. Štupar Janez; Vrtovec Matjaž; Dolinšek Franci
    Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus
    2007 ►
  39. Haehling SV; Lainščak M; Anker SD
    Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?
    2007 ►
  40. Globočnik-Petrovič Mojca; Cilenšek Ines; Petrovič Daniel
    Manganese superoxide dismutase gene polymorphism (V16A) is associated with diabetic retinopathy in Slovene (Caucasians) type 2 diabetes patients
    2008 ►
  41. Smrke Dragica; Gubina Borut; Domanović Dragoslav; Rožman Primož
    Allogeneic platelet gel with autologous cancellous bone graft for the treatment of a large bone defect
    2007 ►
  42. Kariž Stojan; Milutinovič Aleksandra; Bregar Dejan; Terzić Ibrahim; Terzić Rifet; Lovrečić Luca; Herova Magdalena; Hruškovičova Helena; Peterlin Borut; Petrovič Danijel; Zorc-Pleskovič Ruda
    The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in Slovene population with type 2 diabetes
    2007 ►
  43. Globočnik-Petrovič Mojca
    Vpliv genetskih in biokemičnih dejavnikov na napredovanje in zdravljenje diabetične retinopatije pri diabetesu tipa 2
    [The influence of genetical and biochemical factors for the progression and treatment of diabetic retinopathy in type 2 diabetes]
    2007 ►
  44. Vermeire Etienne; Hearnshaw Hilary; Raetsep Anneli; Levasseur Gwenola; Petek Davorina; van Dam Henk; van der Horst Frans; Vinter-Repalust Nevenka
    Obstacles to adherence in living with type-2 diabetes: an international qualitative study using meta-ethnography (EUROBSTACLE)
    2007 ►
  45. Urbančič-Rovan V; Meglič B; Stefanovska A; Bernjak A; Ažman-Juvan K; Kocijančič A
    Incipient cardiovascular autonomic imbalance revealed by wavelet analysis of heart rate variability in type 2 diabetic patients
    2007 ►
  46. Janež Andrej
    Zdravljenje sladkorne bolezni tipa 2 z insulinom
    2002 ►
  47. Mrevlje Franc
    Zdravljenje sladkorne bolezni tipa 2 s peroralnimi antidiabetiki in insulinom
    2006 ►
  48. Medvešček Marko
    Celostna obravnava bolnika s sladkorno boleznijo tipa 2 za zmanjšanje srčno-žilne ogroženosti in merila za kakovosten nadzor dejavnikov tveganja
    2006 ►
  49. Medvešček Marko
    Značilnosti sladkorne bolezni tipa 2 in možnosti za njeno preprečevanje
    2006 ►
  50. Ravnik Maja
    Sladkorna bolezen tipa 2
    2004 ►
  51. Ravnik-Oblak Maja
    Etiopatogeneza in etiologija sladkorne bolezni
    2006 ►
  52. Petrovič Danijel; Verhovec Renata; Globočnik-Petrovič Mojca; Osredkar Joško; Peterlin Borut
    Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes
    2007 ►
  53. Vrtovec Matjaž
    Debel sladkorni bolnik tipa 2
    2006 ►
  54. Mrevlje Franc; Lajovic Jaro; Senčar-Božič Petra
    Rezultati raziskave NovoMix 30 FlexPen v Sloveniji
    2006 ►
  55. Janež Andrej
    Incretin mimetics
    2006 ►
  56. Medvešček Marko
    Strategija uvajanja trajnega zdravljenja z insulinom pri diabetikih tipa 2
    2006 ►
  57. Medvešček Marko; Niewada Maciej
    Urejenost dejavnikov tveganja pri visoko ogroženih diabetikih: primerjava Slovenije in 7 držav srednje in vzhodne Evrope (raziskava DEPAC)
    2006 ►
  58. Milutinovič A; Petrovič D
    The K469E polymorphism of the intracellular adhesion molecule 1 (ICAM-1) gene is not associated with myocardial infarction in Caucasians with type 2 diabetes
    2006 ►
  59. Mori-Lukančič M; Jorgensen H V; Vidic F; Lukančič-Mori Č
    Improving knowledge and glycemic control in patients with type 2 diabetes using a didactic game
    2006 ►
  60. Galič E; Vrtovec M; Bozikov V; Schwarzenhofer M; Miličevič Z
    The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes
    2005 ►
  61. Noč Marko; Janež Andrej
    Akutni srčni infarkt z elevacijo ST (STEMI) in hiperglikemija ob sprejemu
    2006 ►
  62. Fras Zlatko; Medvešček Marko
    Slovenska priporočila za klinično obravnavo oseb z metaboličnim sindromom
    [Slovene recommendations for clinical treatment of individuals with metabolic syndrome]
    2006 ►
  63. Kravos Andrej
    Debelost in pridružene bolezni
    2005 ►
  64. Govc-Eržen Jana
    Preventiva srčnožilnih bolezni ter sočasne bolezni in stanja
    2005 ►
  65. Žirovnik-Kuster Katarina
    Kakovost vodenja sladkornih bolnikov tipa 2 v ambulanti družinske medicine
    2004 ►
  66. Zavratnik Andrej
    Sodobni pogledi na zdravljenje sladkorne bolezni s peroralnimi zdravili
    2005 ►
  67. Zorc-Pleskovič Ruda; Teran Nataša; Pleskovič Aleš; Milutinović Aleksandra
    Deletion/deletion genotype of angiotensin-I converting enzyme gene is not associated with coronary artery disease in Caucasians with type 2 diabetes
    2005 ►
  68. Pfeifer Marija
    Morbidna debelost
    [Morbid obesity]
    2005 ►
  69. Urbančič-Rovan Vilma; Gubina M
    Bacteria in superficial diabetic foot ulcers
    2000 ►
  70. Medvešček Marko
    Metabolični sindrom: opredelitev in klinični pomen
    2005 ►
  71. Vrtovec Matjaž; Vrtovec Bojan; Briški Alenka; Kocijančič Andreja; Anderson Richard A; Radovančević Branislav
    Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus
    2005 ►
  72. Jesenšek-Papež Breda; Tominc Stanko; Turk Zmago; Škafar Marija
    Usporedba utjecaja hidrokineziterapije u termalnoj i običnoj vodi u bolesnika sa šećernom bolešću tipa II
    [Comparing the influence of hydrokinesiotherapy in thermal and ordinary pool water in patients with type II diabetes]
    2005 ►
  73. Janša Karmen
    Metabolic syndrome and cardiovascular risk in women with previous gestational diabetes mellitus
    2005 ►
  74. Medvešček Marko
    The metabolic syndrome
    2005 ►
  75. Janež Andrej
    Insulin resistance
    2005 ►
  76. Pfeifer Marija
    Centralna debelost in presnovni sindrom: trebušna maščoba - tempirana bomba
    2005 ►
  77. Medvešček Marko
    Sladkorna bolezen tipa 2 - pandemija 21. stoletja
    2004 ►
  78. Medvešček Marko
    Sladkorna bolezen
    2005 ►
  79. Mavri Alenka
    Povezava med metabolnim sindromom, inhibitorjem aktivatorja plazminogena (PAI-1) in aterosklerozo
    [Metabolic syndrome, plasminogen activator inhibitor (PAI-1) and atherosclerosis]
    2005 ►
  80. Tomažič Marjeta
    Zdravstvena oskrba bolnika s sladkorno boleznijo tipa 2 v ambulanti splošne medicine
    2005 ►
  81. Medvešček Marko
    Dislipidemija in sladkorna bolezen tipa 2
    2005 ►
  82. Medvešček Marko
    Srčnožilni zapleti in sladkorna bolezen tipa 2
    2005 ►
  83. Mrevlje Franc
    Zdravljenje sladkorne bolezni tipa 2
    2005 ►
  84. Vrtovec Matjaž
    Telesna vadba v zdravljenju sladkorne bolezni
    2005 ►
  85. Pavčič Maruša; Medvešček Marko
    Prehrana v zdravljenju sladkorne bolezni tipa 2
    2005 ►
  86. Mrevlje Franc
    Zdravljenje sladkorne bolezni tipa 2
    2005 ►
  87. Janež Andrej; Ravnik-Oblak Maja
    Etiopatogeneza sladkorne bolezni tipa 2
    2005 ►
  88. Ravnik-Oblak Maja
    Opredelitev, razvrstitev, klinična slika, diagnostika in epidemiologija sladkorne bolezni
    2005 ►
  89. Medvešček Marko; Mrevlje Franc; Koselj Miha
    Sladkorna bolezen tipa 2: priročnik za zdravnike
    2005 ►
  90. Kveder Radoslav
    Mikroalbuminurija - pokazatelj sistemske prizadetosti žilja - preprečitev obeta daljše preživetje bolnikov s sladkorno boleznijo tipa 2
    2005 ►
  91. Urbančič Vilma; Vrtovec Matjaž
    Sladkorna bolezen in srčni infarkt
    2004 ►
  92. Šebeštjen Miran
    Dejavniki tveganja in koronarna ogroženost pri bolnikih s sladkorno boleznijo tipa 2
    2004 ►
  93. Justinek Damjan
    Vpliv telesne dejavnosti na raven sladkorja v krvi pri bolnikih s sladkorno boleznijo tipa 2
    2004 ►
  94. Verhovec Renata
    Polimorfizem gena za žilni endotelijski rastni dejavnik - genetski označevalec koronarne bolezni pri bolnikih s sladkorno boleznijo tipa 2
    2005 ►
  95. Vrtovec Matjaž
    Vpliv kroma na presnovo ogljikovih hidratov in lipidov pri bolnikih s sladkorno boleznijo tipa 2
    2004 ►
  96. Petrovič-Globočnik M; Kunej T; Peterlin B; Dovč P; Petrovič D
    Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not
    2005 ►
  97. Petrovič-Globočnik M; Peterlin B; Hawlina M; Petrovič D
    Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in type 2 diabetes in Caucasians
    2005 ►
  98. Vrtovec Bojan; Šinkovec Matjaž; Starc Vito; Radovančević Branislav; Schlegel Todd T
    Coronary artery disease alters ventricular repolarization dynamics in type 2 diabetes
    2005 ►
  99. Poglajen G; Kirbiš J; Milutinović A
    The -455G/A polymorphism of the beta fibrinogen gene and the Bgl II polymorphism of the alpha2beta1 integrin gene and myocardial infarction in patients with type 2 diabetes
    2004 ►
  100. Kirbiš Janez; Milutinović Aleksandra; Steblovnik Klemen; Teran Nataša; Terzić Rifet; Zorc Marjeta
    The -429 T/C and - 374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes
    2004 ►

1 101 201 301  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics